Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Therapeutic effects of human neural progenitor cells derived from placental fibroblasts induced by small molecule compounds under normoxia on Parkinson's disease rat models

PROVIDER: PRJNA933370 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23388556_1.fastq.gz	Fastqsanger.gz
	SRR23388556_2.fastq.gz	Fastqsanger.gz
	SRR23388557_1.fastq.gz	Fastqsanger.gz
	SRR23388557_2.fastq.gz	Fastqsanger.gz
	SRR23388558_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Project description:Small Molecule Compounds VCR Induces Rat Fibroblasts into Neural Progenitor Cells under Hypoxia

| PRJNA793062 | ENA

Proteomic Research of Neuronal Transdifferentiation

Project description:A proteomic study investigating the transdifferentiation of fibroblasts into neurons induced by small-molecule compounds.

2026-07-08 | PXD080722 |

Enrichment, proteome analysis and transplantation of human embryonic stem cell derived dopaminergic progenitors expressing LMX1a

Project description:Despite the progress in safety and efficacy of cell therapy with pluripotent stem cells (PSCs), the presence of residual undifferentiated stem cells or proliferating neural progenitor cells (NPCs) with rostral identity has remained a major challenge. Here we reported the generation of an LMX1A knock-in GFP reporter human embryonic stem cell (hESC) line that marks the early dopaminergic progenitors during neural differentiation. Purified GFP positive cells in vitro exhibited expression of mRNA and proteins that characterized and matched the midbrain dopaminergic identity. Further proteomic analysis of enriched LMX1A+ cells identified several membrane associated proteins including CNTN2, enabling prospective isolation of LMX1A+ progenitor cells. Transplantation of hPSC-derived purified CNTN2+ progenitors enhanced dopamine release from transplanted cells in the host brain and alleviated Parkinson’s disease symptoms in animal models. Our study establishes an efficient approach for purification of large numbers of hPSC-derived dopaminergic progenitors for therapeutic applications.

2018-06-06 | PXD007837 | Pride

Brief exposure to small molecules allows induction of mouse embryonic fibroblasts into neural crest-like precursors

Project description:In this study, we propose a novel method for inducing neuronal cells by briefly exposing them to small-molecule cocktails in a step-by-step manner. Global gene expression analysis with immunohistochemical staining and calcium flux assays reveal the generation of neurons from mouse embryonic fibroblasts (MEFs). In addition, time-lapse imaging of neural precursor-specific enhancer expression and global gene expression analyses show that the neurons are generated by passing through a neural crest-like precursor stage. Consistent with these results, the neural crest-like cells are able to differentiate into neural crest lineage cells, such as sympathetic neurons, adipocytes, osteocytes, and smooth muscle cells. Therefore, these results indicate that brief exposure to chemical compounds could expand and induce a substantial multipotent cell population without viral transduction.

2017-03-22 | GSE78890 | GEO

Perturbed mouse Epiblast Stem Cells (EpiSC) with Retinoic acid and small molecule compounds at different time points

Project description:EpiSC were perturbed for 24h or 36h with Retinoic acid and 10 distinct small molecule compounds, mouse embryonic fibroblasts conditioned media (CM) or control basal media (Mock)

2025-02-03 | GSE197632 | GEO

Enabling phenotypic drug discovery for neurological mitochondrial DNA disorders with patient-derived neural progenitor cells

Project description:Mitochondrial DNA (mtDNA) mutations predominantly cause neurological diseases. Searching for therapeutic strategies is hindered by the absence of viable neural model systems due to the challenges of engineering mtDNA. We demonstrate that neural progenitor cells (NPCs), rapidly obtained from human induced pluripotent stem cells (iPSCs), retain the parental mtDNA profile and exhibit mitochondrial maturation coupled with a metabolic switch away from glycolysis. Altered calcium homeostasis and mitochondrial hyperpolarization, both potential causes of neural impairment, were observed in iPSC-derived NPCs from patients carrying a deleterious homoplasmic mutation in the mitochondrial gene MT-ATP6 (m.9185T>C). Phenotype-based high-content screenings (HCS) with FDA-approved compounds were carried out, leading to the identification of possible innovative counteracting agents. We propose iPSC-derived NPCs, displaying mild proliferative properties and proper genotype/metabotype, as a bona fide model system for the establishment of personalized phenotypic drug discovery for untreatable mtDNA disorders affecting the nervous system. Associated GEO accession number: GSE70071.

2017-01-31 | PXD004977 | Pride

Expression analysis of neural progenitor cells derived from iPS cells generated from skin fibroblasts and umbilical cord mesenchymal cells

Project description:Investigation of whole genome gene expression level changes in neural progenitor cells derived from iPS cells generated from umbilical cord mesenchymal cells, compared to neural progenitor cells derived from iPS cells generated fromskin fibroblasts. Analyze the difference between neural progenitor cells derived from iPS cells generated from different origins. The method to induce reprogramming of somatic cells and human iPS cells for neural differentiation is described in Cai J, Li W, Su H, Qin D, Yang J, et al. (2010) Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 285: 11227-11234. and Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, et al. (2010) Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev 6: 270-281. A two-chip study using total RNA recovered from one neural progenitor cell line derived from iPS cells generated from skin fibroblasts (GZF1C7NSCP3) and one neural progenitor cell line derived from iPS cells generated from umbilical cord mesenchymal cells (VMC2C7NSCP3). No replicates were made. Each chip measures the expression level of 45,033 genes from the two samples with fourteen 60-mer probe pairs (PM/MM) per gene, with three-fold technical redundancy.

2013-05-06 | E-GEOD-46647 | biostudies-arrayexpress

Optimized Pipeline for Personalized Neurobiological Insights from Single Patient-Derived Neurospheres

Project description:Quantitative proteomic approaches such as TMT labeling enable the amplification of biological material by combining multiple samples into a single analysis. This technique maximizes the data extracted from each sample and allows for precise comparative quantitative analysis between different experimental groups. In this study, we aimed to optimize the workflow for proteomic investigations using neurospheres derived from induced pluripotent stem cells (iPSCs). To improve both the efficiency and accuracy of our proteomic analysis, we compared different protocols and employed Tandem Mass Tag (TMT) labeling. Human neurospheres are three-dimensional, free-floating clusters primarily composed of neural progenitor cells, early-stage neurons, and radial glia. This diverse cell population more closely replicates the complexity of neural development compared to traditional 2D cultures, providing a more relevant model for studying neurogenesis, cell differentiation, and the underlying mechanisms of neurological diseases. Enhancing in vitro models through advanced cell culture techniques is crucial for reducing reliance on animal studies. In neural research, where access to human-relevant data is increasingly feasible, such improvements foster a deeper understanding of neural mechanisms and potential therapeutic targets. The use of 3D cultures represents a significant step forward in accurately modeling neural behavior and disease progression. By optimizing proteomic workflows and employing advanced labeling techniques, this study contributes to the development of more reliable and comprehensive in vitro neural models. This, in turn, supports the broader goal of advancing neural research while reducing reliance on animal models, leading to more ethical and potentially more accurate scientific outcomes that are clinically relevant to humans.

2026-05-19 | PXD057496 | Pride

Enabling phenotypic drug discovery for neurological mitochondrial DNA disorders with patient-derived neural progenitor cells

2017-03-31 | MSV000080849 | MassIVE

Maturation of human iNSCs

Project description:The expression profiles of human iNSCs were compared to skin fibroblasts and brain-derived neural progenitor cells

2017-02-02 | GSE92839 | GEO